Skip to content

Nerve Pain Medicines (Gabapentin and Pregabalin) PDF

How medicines like gabapentin and pregabalin settle nerve pain, why they are built up slowly, their side effects, and using them safely.

If you have been prescribed gabapentin, pregabalin, amitriptyline or duloxetine, you may be surprised — these aren't the painkillers most people reach for. There's a good reason. The pain they treat, nerve pain, behaves differently from ordinary pain, and it needs a different kind of medicine to settle it. Used properly, these are a valuable, non-opioid way to quieten nerve pain down.

What nerve (neuropathic) pain is

Most pain is a sensible alarm: you knock your hand, the tissue is bruised, and the area hurts until it heals. Nerve pain — doctors call it neuropathic pain — is different. Here the problem is the nerve itself: a nerve that has been irritated, squeezed or damaged starts firing off pain signals on its own, even when there's little or nothing wrong with the skin or tissue it reports from. The alarm, in effect, has become faulty and keeps going off.

Nerve pain tends to feel distinctive. People describe it as:

  • Burning or hot
  • Shooting or electric-shock-like, often running along a line
  • Pins and needles, tingling or crawling
  • An area that feels numb but painful at the same time
  • Skin so sensitive that even a light touch or bedsheet hurts

It can come from a trapped nerve such as carpal tunnel syndrome, from a nerve injury or after some operations, from conditions like shingles or diabetes, or from a condition called CRPS (complex regional pain syndrome) where a limb becomes painful and oversensitive after an injury.

Why ordinary painkillers often don't help much

This is the part that surprises people most. Paracetamol, ibuprofen and the other anti-inflammatories work mainly on inflammation and tissue damage — a sprain, a bruise, an operation site. Nerve pain isn't really an inflammation problem; it's an over-active, mis-firing nerve problem. So the usual painkillers, and even strong opioids, often make only a small dent in it.

That's why we turn to a different group of medicines. Rather than calming inflamed tissue, they work on the nervous system itself — turning down the volume on the over-active pain signalling. They were first developed for other purposes (some for epilepsy, some for depression), and along the way they were found to be very good at calming faulty nerve signals. Being prescribed one does not mean we think your pain is imagined or that you have epilepsy or depression — it simply means we're using the medicine for the job it does best.

Gabapentin and pregabalin (Lyrica)

These two are the mainstay of nerve-pain treatment and are closely related. Pregabalin is sold under the brand name Lyrica; gabapentin is also sold as Neurontin.

They work by calming down over-active nerve signalling. An irritated nerve fires partly by letting calcium flow into it through tiny gates called calcium channels; gabapentin and pregabalin dampen those channels, so the nerve fires less easily and fewer pain messages get through. They are not anti-inflammatories and they are not opioids — they're quietening the nerve rather than numbing tissue.

A word of realism: these medicines help nerve pain best when there is genuinely a faulty, over-firing nerve behind it. They are not a good way to manage ordinary aches or the normal soreness after an operation, and taking them routinely "just in case" around surgery isn't recommended — for that kind of pain they add side-effects without adding much relief. They earn their place when nerve pain is the real problem.

Amitriptyline and duloxetine — the alternatives

If gabapentin or pregabalin don't suit you, or don't quite do the job, two other medicines work on the same problem from a different angle.

  • Amitriptyline is an old antidepressant used here at a much lower dose than for depression. At these small doses it helps boost the body's own pain-dampening pathways in the spinal cord and brain. A typical starting dose is very low and taken at night, partly because it can aid sleep — helpful when nerve pain is keeping you awake.
  • Duloxetine is an SNRI (a newer type of antidepressant) that, again, strengthens the natural pain-control signals running through the nervous system. It's a particularly common choice for nerve pain related to diabetes.

As with gabapentin and pregabalin, being offered one of these is about the pain pathway, not your mood.

How these medicines are used — what to expect

A few practical points apply to all of these medicines, and knowing them in advance makes the experience far smoother.

They are started low and built up slowly. You'll usually begin on a small dose and increase it step by step over days to weeks. This isn't caution for its own sake — going slowly lets your body get used to the medicine and lets the early side-effects settle, so you end up tolerating a useful dose that would have floored you if you'd started on it.

They take time to work — they are not instant. Unlike paracetamol, you won't take a tablet and feel relief in half an hour. These medicines build their effect over days to a few weeks, and amitriptyline and duloxetine may need several weeks at a reasonable dose before you can fairly judge them. The single most common reason people miss out on a medicine that would have helped is giving up too early. If it isn't working yet, that often means it needs more time or a higher dose — not that it has failed.

They take the edge off — they rarely switch the pain off completely. It helps to know what success looks like. For most people a good result is the pain becoming quieter and more liveable — say, dropping from severe to mild, or letting you sleep — rather than disappearing altogether. Some people get a lot of relief, some get a little, and some find a particular medicine does nothing for them, which is why it's often a case of trying one and, if needed, switching to another. Pairing the medicine with the rest of your treatment — keeping the hand moving, hand therapy, treating the underlying cause where we can — usually does more than any tablet on its own.

Common side-effects. The usual ones are drowsiness, dizziness and a dry mouth; some people notice weight gain or mild swelling of the ankles. These are usually worst early on and often ease as your body adjusts — which is exactly why we build the dose up gently. Tell us if they're troublesome; slowing down the increases, or adjusting the dose, usually sorts it out.

Driving and alcohol while you settle in. Because these can make you drowsy or lightheaded, be careful with driving or operating machinery until you know how the medicine affects you, especially in the first days and after each dose increase. Go easy on alcohol too, as it adds to the drowsiness.

Don't stop them suddenly. When the time comes to come off one of these medicines, the dose should be reduced gradually (tapered) rather than stopped overnight. Stopping abruptly can cause unpleasant withdrawal effects. Always come off them with guidance, not on your own.

A note on gabapentin and pregabalin as controlled medicines

Gabapentin and pregabalin are now classed as controlled medicines. There are two reasons. First, they carry a risk of misuse and dependence in some people. Second — and most importantly for safety — they can be dangerous when combined with opioids or other sedatives (including strong sleeping tablets and significant alcohol), because together they can slow your breathing.

In practice this means: take them exactly as prescribed, don't share them, don't take extra, and make sure every clinician treating you knows you're on one — especially if anyone is considering prescribing you opioid painkillers or sedatives. We have separate pages on opioids and managing pain after surgery and on cannabis and CBD for pain if those are relevant to you.

None of this should put you off. For the great majority of people these are safe, effective and a genuinely useful non-opioid way to bring nerve pain under control. The controlled-medicine status is simply a reason to use them thoughtfully and only as prescribed.

Seek help if

Contact us, your GP, or seek urgent care if you notice:

  • Severe drowsiness or confusion, or you can't be roused easily
  • Mood changes, or any thoughts of harming yourself — tell someone straight away
  • Breathing problems or unusually slow or shallow breathing — especially if you are also taking an opioid or sedative (call emergency services)
  • Signs of an allergic reaction — a rash, swelling of the face, lips or tongue, or difficulty breathing (this is an emergency)

And do get in touch if the medicine simply isn't helping after a fair trial, or the side-effects are hard to live with — there are several options, and it's usually a matter of finding the one that suits you.


Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.